Lifestyle & Wellness
-

Minimal Yet Meaningful: Candere’s Affordable Luxury Pieces for the Modern Work-Life Routine
In today’s fast-paced world, the definition of luxury is evolving. It’s no longer about saving your finest jewellery for special occasions but it’s about redefining everyday elegance through pieces that complement your rhythm: understated, functional,…
-

Desai & Diwanji Secures Urgent High Court Approval for Life-Saving Liver Transplant in Pro Bono Case
Desai & Diwanji undertook on a pro bono basis the representation of Mr. Arvind Singh (through his constituted attorney and his wife, Mrs. Sharda Singh) a 37-year-old patient battling acute-on-chronic liver failure (ACLF) at Nanavati…
-

Alembic Pharmaceuticals Limited announces USFDA Final Approval for Sumatriptan Injection
Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Sumatriptan Injection USP, 4 mg/0.5 mL and 6…
-

Manipal Hospitals Kolkata Hosts Organ Donation Summit – “Best Practices in Organ Donation”
~ Experts from across India and abroad unite to strengthen organ donation ecosystem in Eastern India ~ ~ For the first time in Asia, Manipal Hospital Dwarka, New Delhi, conducted a deceased organ donation post…
-

Zydus receives tentative approval from USFDA for Olaparib Tablets, 100 mg and 150 mg
Ahmedabad, India : Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received tentative approval from the United States Food and Drug Administration (USFDA) for Olaparib Tablets, 100 mg and 150…
-

Alembic Pharmaceuticals Limited announces USFDA Final Approval for Dasatinib Tablets
Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Dasatinib Tablets, 20 mg, 50 mg, 70 mg,…
